Review: taking Atripla and Benadryl together


Summary

Drug interactions are reported among people who take Atripla and Benadryl together. This review analyzes the effectiveness and drug interactions between Atripla and Benadryl. It is created by eHealthMe based on reports of 42 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Atripla and Benadryl >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Atripla

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. (latest outcomes from Atripla 2,421 users)

Benadryl

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Benadryl 32,636 users)

On Aug, 19, 2016

42 people who take Atripla, Benadryl are studied.


Number of reports submitted per year:

Atripla and Benadryl drug interactions.

Drug effectiveness over time:

Atripla:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 100.0% - (2 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Benadryl:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Atripla:
  • female: 100.0% - (1 of 1 people)
  • male: 80.0% - (4 of 5 people)
Benadryl:
  • female: 0.0% - (0 of 0 people)
  • male: 20.0% - (1 of 5 people)

Drug effectiveness by age:

Atripla:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Benadryl:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • chills
  • dehydration
  • diarrhoea
  • eye pain
  • nausea
  • pyrexia
  • rash maculo-papular
  • rash pruritic
  • agranulocytosis
  • hypersensitivity
1 - 6 months:
  • agranulocytosis
  • rash
  • hepatic steatosis
  • night sweats
  • pruritus
6 - 12 months:
  • night sweats
2 - 5 years:
  • pancreatitis acute
  • rash
not specified:
  • completed suicide
  • insomnia
  • diarrhoea
  • fatigue
  • pruritus
  • syncope
  • headache
  • dehydration
  • nausea
  • blood urine present

Most common drug interactions by gender *:

female:
  • completed suicide
  • nausea
  • anxiety
  • death
  • dysphagia
  • poisoning
  • pruritus
  • pyrexia
  • tachycardia
  • urinary tract infection
male:
  • agranulocytosis
  • diarrhoea
  • fatigue
  • insomnia
  • syncope
  • blood urine present
  • chest pain
  • decreased appetite
  • dehydration
  • dyspnoea

Most common drug interactions by age *:

30-39:
  • angioedema
  • anxiety
  • completed suicide
  • dermatitis bullous
  • drooling
  • dysphagia
  • epidermal necrosis
  • escherichia urinary tract infection
  • hypotension
  • nausea
40-49:
  • pruritus
  • blood urine present
  • chest pain
  • decreased appetite
  • dehydration
  • diarrhoea
  • dyspnoea
  • fatigue
  • headache
  • hyperhidrosis
50-59:
  • completed suicide
  • syncope
  • anaemia
  • death
  • poisoning
  • amnesia
  • anxiety
  • areflexia
  • back pain
  • body tinea
60+:
  • chills
  • dehydration
  • diarrhoea
  • epistaxis
  • eye pain
  • hypersensitivity
  • nausea
  • pyrexia
  • rash maculo-papular
  • rash pruritic

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Atripla and Benadryl?

Can you answer these questions?

More questions for: Atripla, Benadryl

You may be interested in these reviews

More reviews for: Atripla, Benadryl

On eHealthMe, Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate) is often used to treat hiv infection. Benadryl (diphenhydramine hydrochloride) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.